P Sivaramakrishnan Ramamoorthy

Title: P Sivaramakrishnan Ramamoorthy: Innovator in Pharmaceutical Chemistry

Introduction

P Sivaramakrishnan Ramamoorthy is a notable inventor based in Plainsboro, NJ (US). He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of compounds that target serotonin receptors. With a total of 4 patents, his work has implications for treating various mental health disorders.

Latest Patents

His latest patents include innovative compounds such as [1,4]diazepino[6,7,1-IJ]quinoline derivatives, which serve as antipsychotic and antiobesity agents. These compounds are designed to act as 5HT2c agonists or partial agonists, providing therapeutic benefits for a range of disorders. Another significant patent involves 3-amino chroman and 2-amino tetralin derivatives, which are useful for modulating the activity of serotonin receptors. These compounds have potential applications in treating serotonin-related disorders, including depression and anxiety.

Career Highlights

P Sivaramakrishnan Ramamoorthy is currently associated with Wyeth, a prominent pharmaceutical company. His work at Wyeth has allowed him to focus on the development of innovative therapeutic agents that address critical health issues.

Collaborations

He has collaborated with notable colleagues, including Zhongqi Shen and Boyd Lynn Harrison, to advance research in his field. Their combined expertise has contributed to the successful development of new pharmaceutical compounds.

Conclusion

P Sivaramakrishnan Ramamoorthy's contributions to pharmaceutical chemistry highlight his role as an innovator in the industry. His patents reflect a commitment to improving treatments for mental health disorders, showcasing the importance of research and collaboration in advancing medical science.